“…MOFs are the ideal carriers for drug delivery because they can easily be modified with specific molecules and exhibit low toxicity, a large surface area, and nanoenzyme (or nanozyme)‐like properties (Cai et al, 2019; Ding et al, 2020; Sun et al, 2020). Nanozymes are a class of enzyme mimics that display both the unique properties of nanomaterials and the catalytic functions of enzymes (Cao et al, 2020; Duan et al, 2020; Fang et al, 2020; Gao et al, 2007; Wang, Chang, et al, 2020; Wang, Li, et al, 2021; Wang, Wang, et al, 2019; Wei et al, 2021; Zhou, Ouyang, et al, 2021; Zhou, You, et al, 2021).…”